Literature DB >> 6973951

Evaluation of eight cephalosporins in hamster colitis model.

J R Ebright, R Fekety, J Silva, K H Wilson.   

Abstract

Eight commonly used cephalosporins were evaluated in the hamster colitis mode. They were all found to cause hemorrhagic cecitis and death within 10 days of being given as subcutaneous or oral challenges. Necropsy findings were indistinguishable from clindamycin-induced cecitis. Bacteria-free cecal filtrate obtained from hamsters dying of cephalosporin-induced cecitis contained toxin similar or identical to hat produced by Clostridium difficile isolated from the cecum of a hamster. Daily oral administration of poorly absorbed cephalosporins protected hamsters from clindamycin-induced cecitis and death as long as the cephalosporins were continued. The absorbable cephalosporins were ineffective in protecting hamsters from clindamycin-induced cecitis. This difference probably relates to the lower concentrations of absorbable cephalosporins maintained in the ceca of the hamsters. The possible correlation of these findings to human cases of cephalosporin-induced pseudomembranous colitis is discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6973951      PMCID: PMC181595          DOI: 10.1128/AAC.19.6.980

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  The protective effect of vancomycin on clindamycin-induced colitis in hamsters.

Authors:  R A Browne; R Fekety; J Silva; D I Boyd; C O Work; G D Abrams
Journal:  Johns Hopkins Med J       Date:  1977-10

2.  Gastrointestinal and systemic toxicity of fecal extracts from hamsters with clindamycin-induced colitis.

Authors:  G D Rifkin; J Silva; R Fekety
Journal:  Gastroenterology       Date:  1978-01       Impact factor: 22.682

Review 3.  Pseudomembranous enterocolitis (antibiotic-related colitis).

Authors:  J G Bartlett; S L Gorbach
Journal:  Adv Intern Med       Date:  1977

4.  Fatal enterocolitis in hamsters given lincomycin hydrochloride.

Authors:  J D Small
Journal:  Lab Anim Care       Date:  1968-08

5.  Pseudomembranous colitis associated with cephazolin therapy.

Authors:  H J Fee; M E Ament; E C Holmes
Journal:  Am J Surg       Date:  1977-02       Impact factor: 2.565

6.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

7.  Epidemiology of experimental enterocecitis due to Clostridium difficile.

Authors:  H E Larson; A B Price; S P Borriello
Journal:  J Infect Dis       Date:  1980-09       Impact factor: 5.226

8.  Clindamycin-induced enterocolitis in hamsters.

Authors:  R H Lusk; R Fekety; J Silva; R A Browne; D H Ringler; G D Abrams
Journal:  J Infect Dis       Date:  1978-04       Impact factor: 5.226

9.  Cephalosporin-associated pseudomembranous colitis.

Authors:  J F Tures; W F Townsend; H D Rose
Journal:  JAMA       Date:  1976-08-23       Impact factor: 56.272

10.  Clostridium difficile and the aetiology of pseudomembranous colitis.

Authors:  H E Larson; A B Price; P Honour; S P Borriello
Journal:  Lancet       Date:  1978-05-20       Impact factor: 79.321

View more
  9 in total

1.  Fixation of Clostridium difficile toxin A and cholera toxin to intestinal brush border membranes from axenic and conventional mice.

Authors:  F Lucas; G W Elmer; E Brot-Laroche; G Corthier
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

2.  Studies with temocillin in a hamster model of antibiotic-associated colitis.

Authors:  R J Boon; A S Beale
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

3.  In vitro susceptibility of Clostridium difficile isolates to cefotaxime, moxalactam, and cefoperazone.

Authors:  R A Greenfield; T A Kurzynski; W A Craig
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

Review 4.  Models for the study of Clostridium difficile infection.

Authors:  Emma L Best; Jane Freeman; Mark H Wilcox
Journal:  Gut Microbes       Date:  2012-03-01

5.  BMY 28100, a new oral cephalosporin.

Authors:  F Leitner; T A Pursiano; R E Buck; Y H Tsai; D R Chisholm; M Misiek; J V Desiderio; R E Kessler
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

6.  Prairie dog model for antimicrobial agent-induced Clostridium difficile diarrhea.

Authors:  E L Muller; H A Pitt; W L George
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

Review 7.  Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R C Heel
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

8.  Studies with temocillin in the hamster model of antibiotic-associated colitis.

Authors:  R J Boon; A S Beale
Journal:  Drugs       Date:  1985       Impact factor: 9.546

9.  Prevention of clindamycin-induced mortality in hamsters by Saccharomyces boulardii.

Authors:  R D Toothaker; G W Elmer
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.